Henry Schein, Inc. logo
Henry Schein, Inc. (HSIC)
Compare

Henry Schein, Inc. (HSIC) Total Return:9.25%(TTM)

Stocks/HSIC Stock/Performance/total return cagr
Compare

Over the latest trailing 12-month period, Henry Schein, Inc. (HSIC)'s total return cagr is +9.25%. The comparable SPY value is +26.64%. Year-to-date total return is +4.09%. Total return includes price appreciation and reinvested dividends.

Growth of $10,000 in HSIC

$114,633

(11.5x return)

Invested on Jun 24, 1996

Growth of $10,000 in SPY (S&P 500)

$186,505

(18.7x return)

Invested on Jun 24, 1996

Hypothetical Growth of $10,000

This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.

Recent Performance Indicators

YTD Total Return

+4.1%

1-Year Total Return

+9.3%

Current Dividend Yield

0.00%

Price CAGR vs. Total Return CAGR

Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.

Holding PeriodPrice CAGRTotal Return CAGRDividend Addition
1 Year+9.3%+9.3%
3 Years(0.4%)(0.4%)
5 Years+0.6%+0.6%
10 Years+1.4%+1.4%
15 Years+7.2%+7.2%
20 Years+7.7%+7.7%

About Henry Schein, Inc.

Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Melville, NY
25,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Andrea Albertini